4//SEC Filing
Caughey Elaine 4
Accession 0000899243-21-025048
CIK 0001815442other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:36 PM ET
Size
5.6 KB
Accession
0000899243-21-025048
Insider Transaction Report
Form 4
Caughey Elaine
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-21+100,000→ 100,000 totalExercise: $47.56Exp: 2031-06-20→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares underlying this stock option shall vest on June 21, 2022, and the remainder shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001868668
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:36 PM ET
- Size
- 5.6 KB